Tissue transglutaminase mediated tumor-stroma interaction promotes pancreatic cancer progression

Jiyoon Lee, Salvatore Condello, Bakhtiyor Yakubov, Robert Emerson, Andrea Caperell-Grant, Kiyotaka Hitomi, Jingwu Xie, Daniela Matei

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Purpose: Aggressive pancreatic cancer is commonly associated with a dense desmoplastic stroma, which forms a protective niche for cancer cells. The objective of the study was to determine the functions of tissue transglutaminase (TG2), a Ca2-dependent enzyme that cross-links proteins through transamidation and is abundantly expressed by pancreatic cancer cells in the pancreatic stroma. Experimental Design: Orthotopic pancreatic xenografts and coculture systems tested the mechanisms by which the enzyme modulates tumor-stroma interactions. Results: We show that TG2 secreted by cancer cells effectively molds the stroma by cross-linking collagen, which, in turn, activates fibroblasts and stimulates their proliferation. The stiff fibrotic stromal reaction conveys mechanical cues to cancer cells, leading to activation of the YAP/TAZ transcription factors, promoting cell proliferation and tumor growth. Stable knockdown of TG2 in pancreatic cancer cells leads to decreased size of pancreatic xenografts. Conclusions: Taken together, our results demonstrate that TG2 secreted in the tumor microenvironment orchestrates the crosstalk between cancer cells and stroma fundamentally affecting tumor growth. Our study supports TG2 inhibition in the pancreatic stroma as a novel strategy to block pancreatic cancer progression.

Original languageEnglish (US)
Pages (from-to)4482-4493
Number of pages12
JournalClinical Cancer Research
Volume21
Issue number19
DOIs
StatePublished - Oct 1 2015

Fingerprint

Pancreatic Neoplasms
Neoplasms
Heterografts
Tumor Microenvironment
Enzymes
Growth
Coculture Techniques
transglutaminase 2
Cues
Fungi
Research Design
Transcription Factors
Collagen
Fibroblasts
Cell Proliferation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tissue transglutaminase mediated tumor-stroma interaction promotes pancreatic cancer progression. / Lee, Jiyoon; Condello, Salvatore; Yakubov, Bakhtiyor; Emerson, Robert; Caperell-Grant, Andrea; Hitomi, Kiyotaka; Xie, Jingwu; Matei, Daniela.

In: Clinical Cancer Research, Vol. 21, No. 19, 01.10.2015, p. 4482-4493.

Research output: Contribution to journalArticle

Lee, Jiyoon ; Condello, Salvatore ; Yakubov, Bakhtiyor ; Emerson, Robert ; Caperell-Grant, Andrea ; Hitomi, Kiyotaka ; Xie, Jingwu ; Matei, Daniela. / Tissue transglutaminase mediated tumor-stroma interaction promotes pancreatic cancer progression. In: Clinical Cancer Research. 2015 ; Vol. 21, No. 19. pp. 4482-4493.
@article{1d36976f2b5345db9963f3d33e3e975f,
title = "Tissue transglutaminase mediated tumor-stroma interaction promotes pancreatic cancer progression",
abstract = "Purpose: Aggressive pancreatic cancer is commonly associated with a dense desmoplastic stroma, which forms a protective niche for cancer cells. The objective of the study was to determine the functions of tissue transglutaminase (TG2), a Ca2-dependent enzyme that cross-links proteins through transamidation and is abundantly expressed by pancreatic cancer cells in the pancreatic stroma. Experimental Design: Orthotopic pancreatic xenografts and coculture systems tested the mechanisms by which the enzyme modulates tumor-stroma interactions. Results: We show that TG2 secreted by cancer cells effectively molds the stroma by cross-linking collagen, which, in turn, activates fibroblasts and stimulates their proliferation. The stiff fibrotic stromal reaction conveys mechanical cues to cancer cells, leading to activation of the YAP/TAZ transcription factors, promoting cell proliferation and tumor growth. Stable knockdown of TG2 in pancreatic cancer cells leads to decreased size of pancreatic xenografts. Conclusions: Taken together, our results demonstrate that TG2 secreted in the tumor microenvironment orchestrates the crosstalk between cancer cells and stroma fundamentally affecting tumor growth. Our study supports TG2 inhibition in the pancreatic stroma as a novel strategy to block pancreatic cancer progression.",
author = "Jiyoon Lee and Salvatore Condello and Bakhtiyor Yakubov and Robert Emerson and Andrea Caperell-Grant and Kiyotaka Hitomi and Jingwu Xie and Daniela Matei",
year = "2015",
month = "10",
day = "1",
doi = "10.1158/1078-0432.CCR-15-0226",
language = "English (US)",
volume = "21",
pages = "4482--4493",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "19",

}

TY - JOUR

T1 - Tissue transglutaminase mediated tumor-stroma interaction promotes pancreatic cancer progression

AU - Lee, Jiyoon

AU - Condello, Salvatore

AU - Yakubov, Bakhtiyor

AU - Emerson, Robert

AU - Caperell-Grant, Andrea

AU - Hitomi, Kiyotaka

AU - Xie, Jingwu

AU - Matei, Daniela

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Purpose: Aggressive pancreatic cancer is commonly associated with a dense desmoplastic stroma, which forms a protective niche for cancer cells. The objective of the study was to determine the functions of tissue transglutaminase (TG2), a Ca2-dependent enzyme that cross-links proteins through transamidation and is abundantly expressed by pancreatic cancer cells in the pancreatic stroma. Experimental Design: Orthotopic pancreatic xenografts and coculture systems tested the mechanisms by which the enzyme modulates tumor-stroma interactions. Results: We show that TG2 secreted by cancer cells effectively molds the stroma by cross-linking collagen, which, in turn, activates fibroblasts and stimulates their proliferation. The stiff fibrotic stromal reaction conveys mechanical cues to cancer cells, leading to activation of the YAP/TAZ transcription factors, promoting cell proliferation and tumor growth. Stable knockdown of TG2 in pancreatic cancer cells leads to decreased size of pancreatic xenografts. Conclusions: Taken together, our results demonstrate that TG2 secreted in the tumor microenvironment orchestrates the crosstalk between cancer cells and stroma fundamentally affecting tumor growth. Our study supports TG2 inhibition in the pancreatic stroma as a novel strategy to block pancreatic cancer progression.

AB - Purpose: Aggressive pancreatic cancer is commonly associated with a dense desmoplastic stroma, which forms a protective niche for cancer cells. The objective of the study was to determine the functions of tissue transglutaminase (TG2), a Ca2-dependent enzyme that cross-links proteins through transamidation and is abundantly expressed by pancreatic cancer cells in the pancreatic stroma. Experimental Design: Orthotopic pancreatic xenografts and coculture systems tested the mechanisms by which the enzyme modulates tumor-stroma interactions. Results: We show that TG2 secreted by cancer cells effectively molds the stroma by cross-linking collagen, which, in turn, activates fibroblasts and stimulates their proliferation. The stiff fibrotic stromal reaction conveys mechanical cues to cancer cells, leading to activation of the YAP/TAZ transcription factors, promoting cell proliferation and tumor growth. Stable knockdown of TG2 in pancreatic cancer cells leads to decreased size of pancreatic xenografts. Conclusions: Taken together, our results demonstrate that TG2 secreted in the tumor microenvironment orchestrates the crosstalk between cancer cells and stroma fundamentally affecting tumor growth. Our study supports TG2 inhibition in the pancreatic stroma as a novel strategy to block pancreatic cancer progression.

UR - http://www.scopus.com/inward/record.url?scp=84945393660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945393660&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-15-0226

DO - 10.1158/1078-0432.CCR-15-0226

M3 - Article

C2 - 26041746

AN - SCOPUS:84945393660

VL - 21

SP - 4482

EP - 4493

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 19

ER -